Aug 7, 2026 09:00AM

Jul 20, 2026 09:00AM

Jul 9, 2026 01:36PM

Jul 9, 2026 01:35PM

Jul 9, 2026 07:30AM

Jul 9, 2026 07:30AM

Jun 24, 2026 09:01AM Virax Biolabs announces 1-for-25 reverse stock split on Nasdaq

Jun 24, 2026 09:00AM

May 26, 2026 07:31AM

May 26, 2026 07:30AM

May 15, 2026 09:00AM

Apr 14, 2026 07:34AM

Mar 31, 2026 07:34AM

Mar 31, 2026 07:34AM Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation

Dec 4, 2025 04:05PM

Dec 4, 2025 04:05PM

Dec 3, 2025 01:54PM

Dec 3, 2025 01:53PM

Dec 3, 2025 07:34AM

Dec 3, 2025 07:34AM

Nov 3, 2025 08:29AM Virax Biolabs completes UK clinical study recruitment ahead of schedule

Nov 3, 2025 08:29AM

Aug 26, 2025 07:34AM

Aug 26, 2025 07:30AM

Jul 29, 2025 07:36AM

Jul 29, 2025 07:35AM

Jul 18, 2025 04:15PM

Jul 18, 2025 04:15PM Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Jul 18, 2025 04:15PM

Mar 18, 2025 07:31AM

Mar 18, 2025 07:30AM

Mar 13, 2025 07:30AM

Mar 13, 2025 07:30AM

Feb 25, 2025 07:04AM

Feb 25, 2025 07:00AM Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy

Dec 17, 2024 07:32AM

Dec 17, 2024 07:30AM

Aug 23, 2024 04:09PM

Aug 21, 2024 09:30PM

Apr 25, 2024 08:00AM

Apr 16, 2024 07:30AM

Mar 15, 2024 04:31PM Virax Biolabs Group (VRAX) Receives Nasdaq Non-compliance Notice

Mar 15, 2024 04:30PM

Dec 21, 2023 07:31AM

Dec 21, 2023 07:30AM

Dec 14, 2023 07:30AM

Dec 14, 2023 07:30AM

Sep 12, 2023 07:30AM

Sep 1, 2023 07:31AM Virax Biolabs Group (VRAX) Appoints Nigel McCracken as COO

Sep 1, 2023 07:30AM

1,219,730 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All